Tuberc Respir Dis.  2009 Oct;67(4):364-368.

A Case of Bronchiolitis Interstitial Pneumonitis

Affiliations
  • 1Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea. yskwon@chonnam.ac.kr
  • 2Department of Pathology, Chonnam National University Medical School, Gwangju, Korea.
  • 3Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School, Gwangju, Korea.
  • 4Department of Radiology, Chonnam National University Medical School, Gwangju, Korea.

Abstract

Bronchiolitis interstitial pneumonitis (BIP), an unclassified and newly described interstitial pneumonia, has a combined feature of prominent bronchiolitis, interstitial inflammation, and fibrosis. It is distinct from bronchiolitis obliterans or bronchiolitis obliterans organizing pneumonia (BOOP). BIP has a better prognosis than common cases of interstitial pneumonia. However, BIP has a poorer prognosis than BOOP. BIP's response to corticosteroids is not as successful as BOOP's response to this treatment. We encountered the case of a 31-year-old woman with BIP with an initial presentation of dyspnea and a cough that had lasted for 3 months. The patient's chest CT scan demonstrated patchy ground glass opacities and multiple ill-defined centrilobular nodules in both lungs, suggesting military tuberculosis or nontuberculous mycobacterial infection. A video-assisted thoracoscopic lung biopsy resulted in the diagnosis of BIP. Clinical symptoms, pulmonary lesions, and pulmonary function tests were improved after oral glucocorticoid therapy.

Keyword

Interstitial lung diseases; Bronchiolitis; Bronchiolitis obliterans

MeSH Terms

Adrenal Cortex Hormones
Adult
Biopsy
Bronchiolitis
Bronchiolitis Obliterans
Cough
Cryptogenic Organizing Pneumonia
Dyspnea
Female
Fibrosis
Glass
Humans
Inflammation
Lung
Lung Diseases, Interstitial
Military Personnel
Prognosis
Respiratory Function Tests
Thorax
Tuberculosis
Adrenal Cortex Hormones

Figure

  • Figure 1 Radiologic findings of a patient with bronchiolitis interstitial pneumonitis before and after glucocorticoid therapy. (A) Initial chest radiography shows diffuse fine reticulonodular opacities and mixed multiple patchy opacities with peripheral predominance in both lungs. There is also fibrocalcified lesion in left upper lung field which is suggestive of inactive pulmonary TB lesion. (B) Follow-up chest radiography after completion of glucocorticoid therapy shows a marked resolution of diffuse fine reticulonodular opacities and mixed patchy opacities in both lungs. (C) An initial chest HRCT image (lung window setting) at the level of lower hemithorax shows bilateral symmetric multiple patchy areas of peribronchial ground-glass opacities (GGOs), diffuse bronchial and bronchiolar wall thickening, and mixed ill-defined centrilobular nodules in both lungs. (D) A follow-up chest HRCT image (lung window setting) at the same level of image of (C) after completion of glucocorticoid theraphy shows marked improvement of multiple patchy areas of peribronchial GGOs, diffuse bronchial and bronchiolar wall thickening, and mixed ill-defined centrilobular nodules in both lungs.

  • Figure 2 The pathologic findings of lung specimen resected by video-assisted thoracoscopic surgery. (A) Resected lung specimen shows an architectural alteration of pulmonary alveolar structures and diffuse interstitial thickening (H&E stain, ×40). (B) The bronchiole shows a dilatation of bronchiole, mucostasis, and smooth muscle hyperplasia (H&E stain, ×100). (C) In peribronchiolar portion, mild interstitial thickening and fibrosis are predominantly shown (H&E stain, ×100).


Reference

1. David M Mitchell, Ashley Woodcock. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction. Thorax. 1999. 54:Suppl 1. S1–S14.
2. American Thoracic Society. European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002. 165:277–304.
3. Churg A, Myers J, Suarez T, Gaxiola M, Estrada A, Mejia M, et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol. 2004. 28:62–68.
4. Fukuoka J, Franks TJ, Colby TV, Flaherty KR, Galvin JR, Hayden D, et al. Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am J Surg Pathol. 2005. 29:948–954.
5. Mark EJ, Ruangchira-urai R. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation. Ann Diagn Pathol. 2008. 12:171–180.
6. Yousem SA, Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod Pathol. 2002. 15:1148–1153.
7. Qureshi RA, Ahmed TA, Grayson AD, Soorae AS, Drakeley MJ, Page RD. Does lung biopsy help patients with interstitial lung disease? Eur J Cardiothorac Surg. 2002. 21:621–626. discussion 626.
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr